Eton Pharma Chief Business Officer David Krempa sells 4,166 common shares for $229,405.56
ETON•Eton Pharmaceuticals Chief Business Officer David Krempa sold 4,166 common shares on Oct. 6, 2026, for $229,405.56, leaving him with 43,381 shares.
1. Share sale and holdings
Krempa sold the shares at $55.0663 each. He had acquired 10,522 shares on Oct. 2 through restricted stock unit vesting.
